In a landmark moment for its oncology ambitions, GSK has secured FDA approval for Jideytro (zidesamtinib) as the first ...

When your e-bike battery percentage jumps up and down, it can be difficult to know how much riding range you actually have left. Your display might show 65%, fall to 48% while climbing a hill, and ...

The EIS engine embedded in TI’s latest battery cell monitor could make a big difference in battery energy storage systems.

After travelling nearly two hours to watch Cigarettes After Sex perform in Bengaluru last year, Ushma Mehrotra was already at the venue when she learnt the conc ...

From government schemes and battery technology to running costs and after-sales support, here is what every first-time EV ...

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...

Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol Myers Squibb (BMY) reached $60.48 at the closing of the latest trading day, reflecting a +2.99% change compared to ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today announced that it has entered into a global collaboration and license agreement with Incyte to evaluate additional subcutaneous ...